"Sometimes, I think I might say too much": Dark Secrets and the Performance of Inflammatory Bowel Disease

被引:18
|
作者
Thompson, Alex I. [1 ]
机构
[1] Univ Colorado, Boulder, CO 80309 USA
关键词
chronic illness; dramaturgy; embodiment; narrative self; stigma; SEXUAL DYSFUNCTION; CROHNS-DISEASE; WOMEN; SELF; CONSTRUCTION; TELEVISION; COMMITMENT; SOCIOLOGY; DEVIANCE; IDENTITY;
D O I
10.1002/symb.50
中图分类号
C91 [社会学];
学科分类号
030301 ; 1204 ;
摘要
This study examines the dramaturgical embodiment of chronically ill bodies managing fecal matters (Weinberg and Williams 2005) in Inflammatory Bowel Disease (IBD) support groups. Data were derived from my reflections as a person with IBD, a year of participant observation, and semi-structured interviews with support group members. I first uncover the boundaries of the private body (Cahill 2006). Secondly, I focus on the entrenchment of IBD within the stigma of fecal matters. Lastly, I explore the disparate ways that support group members harnessed language to protect their embodied selves from symbolic fecal contamination, from a soiled self.
引用
下载
收藏
页码:21 / 39
页数:19
相关论文
共 50 条
  • [41] Oral administration of human carbonic anhydrase I suppresses colitis in a murine inflammatory bowel disease model
    Kazuhiro Tange
    Sen Yagi
    Eiji Takeshita
    Masanori Abe
    Yasunori Yamamoto
    Hideomi Tomida
    Tomoe Kawamura
    Masakazu Hanayama
    Bunzo Matsuura
    Yoshiou Ikeda
    Yoichi Hiasa
    Scientific Reports, 12
  • [42] IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease
    Li, Jun-Yi
    Xiao, Jun
    Gao, Min
    Zhou, Hai-Feng
    Fan, Heng
    Sun, Fei
    Cui, Dan-Dan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
  • [43] ApoA-I Mimetic Peptide 4F Inhibits Inflammatory Bowel Disease in Mice
    Meriwether, David
    Volpe, Carmen
    Grijalva, Victor
    Mukherjee, Pallavi
    Martin, Martin
    Anantharamaiah, G. M.
    Fogelman, Alan M.
    Reddy, Srinivasa T.
    CIRCULATION, 2016, 134
  • [44] RELATIONSHIP OF TYPE-I PROCOLLAGEN TO CORTICOSTEROID-THERAPY IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE
    HYAMS, JS
    MOORE, RE
    LEICHTNER, AM
    CAREY, DE
    GOLDBERG, BD
    JOURNAL OF PEDIATRICS, 1988, 112 (06): : 893 - 898
  • [45] Chromoendoscopy Is Better: So Why Am I Not (yet) Using it for Routine Inflammatory Bowel Disease Surveillance?
    Ananthakrishnan, Ashwin N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (05) : 720 - 722
  • [46] Insulin-Like Growth Factor I Receptor Inhibitor-Induced Inflammatory Bowel Disease
    Murone, Julie
    Reinhart, Evan
    El-Hachem, Sandra
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1798 - S1798
  • [47] Oral administration of human carbonic anhydrase I suppresses colitis in a murine inflammatory bowel disease model
    Tange, Kazuhiro
    Yagi, Sen
    Takeshita, Eiji
    Abe, Masanori
    Yamamoto, Yasunori
    Tomida, Hideomi
    Kawamura, Tomoe
    Hanayama, Masakazu
    Matsuura, Bunzo
    Ikeda, Yoshiou
    Hiasa, Yoichi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [48] USE OF TYPE-I PROCOLLAGEN AS A BIOCHEMICAL MARKER OF GROWTH IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE
    HYAMS, JS
    CAREY, DE
    LEICHTNER, AM
    GOLDBERG, BD
    GASTROENTEROLOGY, 1985, 88 (05) : 1425 - 1425
  • [49] G(I2)ALPHA PROTEIN-DEFICIENCY - A MODEL FOR INFLAMMATORY BOWEL-DISEASE
    RUDOLPH, U
    FINEGOLD, MJ
    RICH, SS
    HARRIMAN, GR
    SRINIVASAN, Y
    BRABET, P
    BRADLEY, A
    BIRNBAUMER, L
    JOURNAL OF CLINICAL IMMUNOLOGY, 1995, 15 (06) : S101 - S105
  • [50] LONGITUDINAL ASSESSMENT OF TYPE-I PROCOLLAGEN IN CHILDREN WITH INFLAMMATORY BOWEL-DISEASE SUBJECTED TO SURGERY
    HYAMS, JS
    MOORE, RE
    LEICHTNER, AM
    CAREY, DE
    GOLDBERG, BD
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1989, 8 (01): : 68 - 74